Clinical Trials Browser

Phase NA × UNKNOWN × Sorafenib × Clear all

NCT02537158 2016-03-15

Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular